regulation of CD80 production

Any process that modulates the frequency, rate or extent of CD80 biosynthetic process.


positive regulation of lipoprotein metabolic process

biolink:BiologicalProcess biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids.


regulation of blood coagulation, intrinsic pathway

Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.


translational readthrough

The continuation of translation beyond a stop codon by the use of a special tRNA that recognizes the UAG and UGA codons as modified amino acids, rather than as termination codons.


positive regulation of amide catabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of amides.


regulation of histone H3-K9 trimethylation

Any process that modulates the frequency, rate or extent of histone H3-K9 trimethylation.


negative regulation of translation initiation in response to endoplasmic reticulum stress

Any process that stops, prevents, or reduces the frequency, rate or extent of translation initiation as a result of endoplasmic reticulum stress.


regulation of histone H3-K9 dimethylation

Any process that modulates the frequency, rate or extent of histone H3-K9 dimethylation.


regulation of urea catabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of urea.


regulation of peptidyl-tyrosine autophosphorylation

Any process that modulates the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.


regulation of ferricrocin biosynthetic process

Any process that modulates the frequency, rate or extent of ferricrocin biosynthetic process.


positive regulation of histone H2A K63-linked ubiquitination

Any process that activates or increases the frequency, rate or extent of histone H2A K63-linked ubiquitination.


negative regulation of peptidyl-L-cysteine S-palmitoylation

Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-L-cysteine S-palmitoylation.


sucrose induced translational repression

Any process that stops, prevents or reduces the rate of translation as a result of increase in sucrose level.


negative regulation of protein desumoylation

Any process that decreases the frequency, rate or extent of protein desumoylation. Protein desumoylation is the process in which a SUMO protein (small ubiquitin-related modifier) is cleaved from its target protein.


regulation of protein adenylylation

Any process that modulates the frequency, rate or extent of protein adenylylation.


regulation of glycoprotein metabolic process

Any process that modulates the frequency, rate or extent of glycoprotein metabolic process.


regulation of protein desumoylation

Any process that modulates the frequency, rate or extent of protein desumoylation. Protein desumoylation is the process in which a SUMO protein (small ubiquitin-related modifier) is cleaved from its target protein.


negative regulation of brain-derived neurotrophic factor-activated receptor activity

Any process that stops, prevents, or reduces the frequency, rate or extent of brain-derived neurotrophic factor-activated receptor activity.


regulation of protein acetylation

Any process that modulates the frequency, rate or extent of protein acetylation.


regulation of cap-independent translational initiation

Any process that modulates the frequency, rate or extent of cap-independent translational initiation.


negative regulation of CD80 production

Any process that stops, prevents or reduces the frequency, rate or extent of CD80 biosynthetic process.


positive regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process

Any process that activates or increases the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process.


positive regulation of histone H3-K27 trimethylation

Any process that activates or increases the frequency, rate or extent of histone H3-K27 trimethylation.


positive regulation of Toll receptor ligand protein activation cascade

Any process that activates or increases the frequency, rate or extent of Toll receptor ligand protein activation cascade.


negative regulation of emericellamide biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of emericellamide biosynthetic process.


positive regulation of protein activation cascade

Any process that activates or increases the frequency, rate or extent of protein activation cascade.


regulation of emericellamide A biosynthetic process

Any process that modulates the frequency, rate or extent of emericellamide A biosynthetic process.


positive regulation of peptide hormone processing

Any process that increases the rate, frequency or extent of peptide hormone processing. Peptide hormone processing is the generation of a mature peptide hormone by posttranslational processing of a prohormone.


regulation of N-terminal peptidyl-methionine acetylation

Any process that modulates the frequency, rate or extent of N-terminal peptidyl-methionine acetylation.


negative regulation of kinin cascade

Any process that stops, prevents, or reduces the frequency, rate, or extent of the kinin cascade.


positive regulation of histone H3-K9 trimethylation

Any process that activates or increases the frequency, rate or extent of histone H3-K9 trimethylation.


negative regulation of plasma kallikrein-kinin cascade

Any process that stops, prevents, or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.


regulation of lymphotoxin A production

Any process that modulates the frequency, rate, or extent of lymphotoxin A production.


negative regulation of histone deacetylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the removal of acetyl groups from histones.


positive regulation of elastin biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of elastin.


negative regulation of protein modification process

Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent alteration of one or more amino acid residues within a protein.


regulation of cytoplasmic translational initiation

Any process that modulates the frequency, rate or extent of cytoplasmic translational initiation.


modification by virus of host polysomes

Any viral process that interferes with and inhibits the assembly and function of polysomes.


regulation of peptidyl-L-cysteine S-palmitoylation

Any process that modulates the frequency, rate or extent of peptidyl-L-cysteine S-palmitoylation.


regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process

Any process that modulates the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process.


negative regulation of protein geranylgeranylation

Any process that stops, prevents or reduces the frequency, rate or extent of protein geranylgeranylation.


positive regulation of blood coagulation, intrinsic pathway

Any process that activates or increases the frequency, rate or extent of blood coagulation, intrinsic pathway.


positive regulation of protein polyglycylation

Any process that activates or increases the frequency, rate or extent of protein polyglycylation.


zymogen inhibition

Any process that prevents the proteolytic processing of an inactive enzyme to an active form.


positive regulation of mitochondrial translation in response to stress

Any process that activates or increases the frequency, rate or extent of mitochondrial translation as a result of a stimulus indicating the organism is under stress.


regulation of SUMO transferase activity

Any process that modulates the frequency, rate or extent of SUMO ligase activity.


regulation of proteolysis associated with antigen processing and presentation

Any process that modulates the frequency, rate, or extent of proteolysis associated with antigen processing and presentation.


regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation

Any process that modulates the frequency, rate or extent of endoplasmic reticulum stress-induced eIF2alpha dephosphorylation.


positive regulation of translation, ncRNA-mediated

Any process, mediated by small non-coding RNAs, that activates or increases the rate that mRNAs are effectively translated into protein.


negative regulation of antibacterial peptide biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis.


regulation of N-terminal protein palmitoylation

Any process that modulates the rate frequency or extent of the covalent attachment of a palmitoyl group to the N-terminal amino acid residue of a protein.


regulation of histone H4 acetylation

Any process that modulates the rate, frequency, or extent of histone H4 acetylation, the modification of histone H4 by the addition of an acetyl group.


regulation of protein processing in phagocytic vesicle

Any process that modulates the frequency, rate or extent of protein processing in phagocytic vesicle.


negative regulation of histone H3-K27 trimethylation

Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K27 trimethylation.


regulation of amide catabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of amides.


regulation of histone H3-K9 acetylation

Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.


negative regulation of emericellamide A biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of emericellamide A biosynthetic process.


negative regulation of cap-independent translational initiation

Any process that stops, prevents or reduces the frequency, rate or extent of cap-independent translational initiation.


regulation of protein processing involved in protein targeting to mitochondrion

Any process that modulates the frequency, rate or extent of protein processing involved in protein targeting to mitochondrion.


regulation of ferrichrome biosynthetic process

Any process that modulates the frequency, rate or extent of ferrichrome biosynthetic process.


regulation of oskar mRNA translation

Any process that modulates the frequency, rate or extent of oskar mRNA translation. To ensure the localization of Oskar protein at the posterior pole of the oocyte, translation of oskar mRNA is repressed during its transport to the posterior pole and activated upon localization of the mRNA at the posterior cortex.


regulation of serine-type peptidase activity

Any process that modulates the frequency, rate or extent of serine-type peptidase activity.


negative regulation of translational termination

Any process that stops, prevents, or reduces the frequency, rate or extent of translational termination.


suppression by virus of host translation termination

Any viral process that stops, prevents, or reduces the frequency, rate or extent of translational termination of a host mRNA.


regulation of protein oxidation

Any process that modulates the frequency, rate or extent of protein oxidation.


regulation of antimicrobial peptide biosynthetic process

Any process that modulates the frequency, rate, or extent of antimicrobial peptide biosynthesis.


regulation of protein K63-linked deubiquitination

Any process that modulates the frequency, rate or extent of protein K63-linked deubiquitination.


regulation of histone H2A K63-linked ubiquitination

Any process that modulates the frequency, rate or extent of histone H2A K63-linked ubiquitination.


regulation of pseurotin A biosynthetic process

Any process that modulates the frequency, rate or extent of pseurotin A biosynthetic process.


regulation of brain-derived neurotrophic factor-activated receptor activity

Any process that modulates the frequency, rate or extent of brain-derived neurotrophic factor-activated receptor activity.


regulation of cap-dependent translational initiation

Any process that modulates the frequency, rate or extent of cap-dependent translational initiation.


regulation of translational initiation in response to starvation

Any process that modulates the frequency, rate or extent of translation initiation, as a result of deprivation of nourishment.


negative regulation of histone H3-K9 methylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3.


regulation of elastin catabolic process

Any process that modulates the rate, frequency or extent of elastin catabolism, the chemical reactions and pathways resulting in the breakdown of elastin.


regulation of histone H2B conserved C-terminal lysine ubiquitination

Any process that modulates the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.


regulation of translation initiation in response to endoplasmic reticulum stress

Any process that modulates the frequency, rate or extent of translation initiation, as a result of endoplasmic reticulum stress.


regulation of formation of translation preinitiation complex

Any process that modulates the frequency, rate or extent of formation of translation preinitiation complex.


negative regulation of histone H3-K9 trimethylation

Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 trimethylation.


regulation of protein catabolic process in the vacuole

Any process that modulates the frequency, rate or extent of protein catabolic process in the vacuole.


negative regulation of exonucleolytic catabolism of deadenylated mRNA

Any process that stops, prevents, or reduces the frequency, rate or extent of exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay.


negative regulation by symbiont of host translation

The process in which a symbiont organism stops, prevents, or reduces the frequency, rate or extent of translation, the chemical reactions and pathways resulting in the formation of a protein, in its host organism.


regulation of blood coagulation, extrinsic pathway

Any process that modulates the frequency, rate or extent of blood coagulation, extrinsic pathway.


negative regulation of myosin light chain kinase activity

Any process that stops, prevents, or reduces the frequency, rate or extent of myosin light chain kinase activity.


positive regulation of histone H4-K20 methylation

Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 20 of histone H4.


regulation of histone H2B ubiquitination

Any process that modulates the frequency, rate or extent of histone H2B ubiquitination.


negative regulation of glutathione biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of glutathione biosynthetic process.


negative regulation of histone H3-K27 methylation

Any process that decreases the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.


regulation of histone deacetylase activity

Any process that modulates the frequency, rate or extent of histone deacetylase activity.


positive regulation of translational initiation in response to osmotic stress

Any process that activates or increases the frequency, rate or extent of translation initiation, as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.


regulation of translation, ncRNA-mediated

Any process, mediated by small non-coding RNAs, that modulates the frequency, rate or extent that mRNAs are effectively translated into protein.


regulation of mitochondrial translational elongation

Any process that modulates the frequency, rate or extent of mitochondrial translational elongation.


positive regulation of urea catabolic process

Any process that activates or increases the frequency, rate or extent of urea catabolic process.


regulation of metalloendopeptidase activity

Any process that modulates the frequency, rate or extent of metalloendopeptidase activity.


negative regulation of protein linear polyubiquitination

Any process that stops, prevents or reduces the frequency, rate or extent of protein linear polyubiquitination.


negative regulation of Toll receptor ligand protein activation cascade

Any process that stops, prevents or reduces the frequency, rate or extent of Toll receptor ligand protein activation cascade.


positive regulation of protein modification by small protein conjugation or removal

Any process that activates or increases the frequency, rate or extent of protein modification by small protein conjugation or removal.


negative regulation of peptide hormone processing

Any process that decreases the rate, frequency or extent of peptide hormone processing. Peptide hormone processing is the generation of a mature peptide hormone by posttranslational processing of a prohormone.


regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria

Any process that modulates the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-negative bacteria.


positive regulation of N-terminal peptidyl-methionine acetylation

Any process that activates or increases the frequency, rate or extent of N-terminal peptidyl-methionine acetylation.


negative regulation of protein maturation

Any process that stops, prevents or reduces the frequency, rate or extent of protein maturation.


regulation of peptidyl-serine dephosphorylation

Any process that modulates the frequency, rate or extent of peptidyl-serine dephosphorylation.


regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process

Any process that modualtes the rate, frequency or extent of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by an SCF (Skp1/Cul1/F-box protein) complex, and mediated by the proteasome.


regulation of myosin light chain kinase activity

Any process that modulates the frequency, rate or extent of myosin light chain kinase activity.


negative regulation of protein catabolic process in the vacuole

Any process that stops, prevents or reduces the frequency, rate or extent of protein catabolic process in the vacuole.


negative regulation of cytoplasmic translational initiation

Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic translational initiation.


regulation of histone deubiquitination

Any process that modulates the frequency, rate or extent of histone deubiquitination.


positive regulation of formation of translation preinitiation complex

Any process that activates or increases the frequency, rate or extent of formation of translation preinitiation complex.


positive regulation of N-terminal peptidyl-serine acetylation

Any process that activates or increases the frequency, rate or extent of N-terminal peptidyl-serine acetylation.


negative regulation of cap-dependent translational initiation

Any process that stops, prevents or reduces the frequency, rate or extent of cap-dependent translational initiation.


negative regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria

Any process that stops, prevents, or reduces the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.


negative regulation of tubulin deacetylase activity

Any process that stops, prevents or reduces the frequency, rate or extent of tubulin deacetylase activity.


regulation of antifungal peptide biosynthetic process

Any process that modulates the frequency, rate, or extent of antifungal peptide biosynthesis.


regulation of protein kinase C activity

Any process that modulates the frequency, rate or extent of protein kinase C activity.


regulation of protein geranylgeranylation

Any process that modulates the frequency, rate or extent of protein geranylgeranylation.


viral translational readthrough

The continuation of translation of a viral mRNA beyond a stop codon by the use of a special tRNA that recognizes the UAG and UGA codons as modified amino acids, rather than as termination codons.


negative regulation of protein histidine kinase activity

Any process that stops, prevents, or reduces the frequency, rate or extent of protein histidine kinase activity.


negative regulation of histone H3-K4 methylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.


negative regulation of translational initiation in response to starvation

Any process that stops, prevents or reduces the rate of translation initiation, as a result of deprivation of nourishment.


positive regulation of exonucleolytic catabolism of deadenylated mRNA

Any process that activates or increases the frequency, rate or extent of exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay.


positive regulation of amide metabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amides.


regulation of siderophore biosynthetic process

Any process that modulates the frequency, rate or extent of siderophore biosynthetic process.


regulation of protein glutathionylation

Any process that modulates the rate, frequency, or extent of protein glutathionylation. Protein glutathionylation is the protein modification process in which a glutathione molecule is added to a protein amino acid through a disulfide linkage.


negative regulation of oskar mRNA translation

Any process that stops, prevents or reduces the rate that oskar mRNAs are effectively translated into protein.


positive regulation of histone H4 acetylation

Any process that increases the rate, frequency, or extent of histone H4 acetylation, the modification of histone H4 by the addition of an acetyl group.


positive regulation of glucosylceramide biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glucosylceramide.


negative regulation of SUMO transferase activity

Any process that stops, prevents or reduces the frequency, rate or extent of SUMO ligase activity.


regulation of histone H3-K27 trimethylation

Any process that modulates the frequency, rate or extent of histone H3-K27 trimethylation.


regulation of protein deneddylation

Any process that modulates the rate, frequency, or extent of protein deneddylation, the removal of a ubiquitin-like protein of the NEDD8 type from a protein.


positive regulation of cytoplasmic translational elongation

Any process that activates or increases the frequency, rate or extent of cytoplasmic translational elongation.


negative regulation of histone H3-K9 acetylation

Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation.


negative regulation of protein activation cascade

Any process that stops, prevents or reduces the frequency, rate or extent of protein activation cascade.


negative regulation of protein oxidation

Any process that stops, prevents or reduces the frequency, rate or extent of protein oxidation.


positive regulation of oskar mRNA translation

Any process that activates or increases the frequency, rate or extent of oskar mRNA translation.


pyrrolysine incorporation

The incorporation of pyrrolysine, also known as lysine methylamine methyltransferase cofactor adduct, into a peptide; uses a special tRNA that recognizes the UAG codon as a modified lysine, rather than as a termination codon. Pyrrolysine may be synthesized as a free amino acid or synthesized from a lysine charged tRNA before its incorporation; it is not a posttranslational modification of peptidyl-lysine; this modification is found in several Methanosarcina methylamine methyltransferases.


negative regulation of histone deacetylase activity

Any process that stops, prevents or reduces the frequency, rate or extent of histone deacetylase activity.


regulation of activation of Janus kinase activity

Any process that modulates the frequency or rate of activation of JAK (Janus Activated Kinase) protein. The activation of JAK protein is the process of introducing a phosphate group to a tyrosine residue of a JAK (Janus Activated Kinase) protein, thereby activating it.


positive regulation of blood coagulation, extrinsic pathway

Any process that activates or increases the frequency, rate or extent of blood coagulation, extrinsic pathway.


eIF2alpha dephosphorylation in response to endoplasmic reticulum stress

The removal of a phosphate group from the translation initiation factor eIF2alpha, as a result of endoplasmic reticulum stress.


negative regulation of translation in response to oxidative stress

Any process that stops, prevents, or reduces the frequency, rate or extent of translation as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.


negative regulation of anaphase-promoting complex-dependent catabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of anaphase-promoting complex-dependent catabolic process.


negative regulation of amide catabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of amides.


negative regulation of siderophore biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of siderophore biosynthetic process.


negative regulation of mitochondrial translational initiation

Any process that stops, prevents, or reduces the frequency, rate or extent of the process preceding formation of the peptide bond between the first two amino acids of a protein in a mitochondrion.


negative regulation of histone deubiquitination

Any process that stops, prevents or reduces the frequency, rate or extent of histone deubiquitination.


regulation of cytoplasmic translation in response to stress

Modulation of the frequency, rate or extent of cytoplasmic translation as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).


regulation of aspartic-type peptidase activity

Any process that modulates the frequency, rate or extent of aspartic-type peptidase activity.


regulation of histone H3-K27 methylation

Any process that modulates the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.


regulation of translation involved in anterior/posterior axis specification

Any process that modulates the frequency, rate or extent of translation of mRNAs that contribute to the specification of the anterior/posterior axis.


regulation of protein-pyridoxal-5-phosphate linkage

Any process that modulates the frequency, rate or extent of protein-pyridoxal-5-phosphate linkage.


regulation of proteolysis involved in protein catabolic process

Any process that modulates the frequency, rate or extent of proteolysis involved in cellular catabolic process.


negative regulation of antifungal peptide biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of antifungal peptide biosynthesis.


positive regulation of blood coagulation, common pathway

Any process that activates or increases the frequency, rate or extent of blood coagulation, common pathway.


positive regulation of pseurotin A biosynthetic process

Any process that activates or increases the frequency, rate or extent of pseurotin A biosynthetic process.


negative regulation of protein polyglycylation

Any process that stops, prevents or reduces the frequency, rate or extent of protein polyglycylation.


regulation of non-membrane spanning protein tyrosine kinase activity

Any process that modulates the frequency, rate or extent of non-membrane spanning protein tyrosine kinase activity.


positive regulation of mitochondrial translational elongation

Any process that activates or increases the frequency, rate or extent of mitochondrial translational elongation.


regulation of translation at presynapse

Any process that regulates translation occurring at the presynapse.


regulation of protein modification by small protein conjugation or removal

Any process that modulates the frequency, rate or extent of protein modification by small protein conjugation or removal.


negative regulation of protein-pyridoxal-5-phosphate linkage

Any process that stops, prevents or reduces the frequency, rate or extent of protein-pyridoxal-5-phosphate linkage.


positive regulation of protein adenylylation

Any process that activates or increases the frequency, rate or extent of protein adenylylation.


positive regulation of plasma kallikrein-kinin cascade

Any process that activates or increases the frequency, rate, or extent of the plasma kallikrein-kinin cascade.


negative regulation of N-terminal peptidyl-methionine acetylation

Any process that stops, prevents or reduces the frequency, rate or extent of N-terminal peptidyl-methionine acetylation.


regulation of translation in response to oxidative stress

Any process that modulates the frequency, rate or extent of translation as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.


negative regulation of pseurotin A biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of pseurotin A biosynthetic process.


regulation of kinin cascade

Any process that modulates the frequency, rate, or extent of the kinin cascade.


negative regulation of protein adenylylation

Any process that stops, prevents or reduces the frequency, rate or extent of protein adenylylation.


regulation of emericellamide biosynthetic process

Any process that modulates the frequency, rate or extent of emericellamide biosynthetic process.


negative regulation of translational initiation in response to osmotic stress

Any process that stops, prevents or reduces the rate of translation initiation, as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.


regulation of protein tyrosine phosphatase activity

Any process that modulates the frequency, rate or extent of protein tyrosine phosphatase activity.


positive regulation of hepatocyte growth factor production

Any process that activates or increases the frequency, rate, or extent of hepatocyte growth factor production.


positive regulation of antifungal peptide biosynthetic process

Any process that activates or increases the frequency, rate, or extent of antifungal peptide biosynthesis.


regulation of inhibitory G protein-coupled receptor phosphorylation

Any process that modulates the frequency, rate or extent of inhibitory G protein-coupled receptor phosphorylation.


negative regulation of lipoprotein oxidation

Any process that stops, prevents, or reduces the frequency, rate or extent of lipoprotein oxidation.


positive regulation of histone H2B ubiquitination

Any process that activates or increases the frequency, rate or extent of histone H2B ubiquitination.


regulation of selenocysteine incorporation

Any process that modulates the frequency, rate or extent of selenocysteine incorporation.


positive regulation of antibacterial peptide biosynthetic process

Any process that activates or increases the frequency, rate, or extent of antibacterial peptide biosynthesis.


positive regulation of elastin catabolic process

Any process that activates or increases the frequency, rate or extent of elastin catabolism, the chemical reactions and pathways resulting in the breakdown of elastin.


piRNA-mediated gene silencing by mRNA destabilization

A cytoplasmic post-transcriptional gene silencing pathway in which piRNAs direct the cleavage of target mRNAs. The target mRNA, often transcribed from a transposable element, is destabilized by the activity of a PIWI class endonuclease within the piRNA-induced silencing complex. This may also be accompanied by mRNA deadenylation and decapping.


positive regulation of FasL production

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of FasL.


regulation of cytoplasmic translational termination

Any process that modulates the frequency, rate or extent of cytoplasmic translational termination.


negative regulation of ferrichrome biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of ferrichrome biosynthetic process.


negative regulation of ferrichrome biosynthetic process in response to iron

Any process that stops, prevents or reduces the rate of ferrichrome biosynthetic process in response to an iron stimulus.


regulation of histone methylation

Any process that modulates the frequency, rate or extent of the covalent addition of methyl groups to histones.


negative regulation of protein K63-linked deubiquitination

Any process that stops, prevents or reduces the frequency, rate or extent of protein K63-linked deubiquitination.


positive regulation of histone H3-K9 methylation

Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3.


regulation of cyclin-dependent protein kinase activity

Any process that modulates the frequency, rate or extent of cyclin-dependent protein kinase activity.


regulation of peptidyl-lysine crotonylation

Any process that modulates the frequency, rate or extent of crotonylation of a lysine residue in a protein.


modulation by symbiont of host translation

The process in which a symbiont organism effects a change in translation, the chemical reactions and pathways resulting in the formation of a protein, in its host organism.


regulation of tissue kallikrein-kinin cascade

Any process that modulates the frequency, rate, or extent of the tissue kallikrein-kinin cascade.


positive regulation of histone H3-K27 methylation

Any process that increases the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.


regulation of FasL production

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of FasL.


negative regulation of tissue kallikrein-kinin cascade

Any process that stops, prevents, or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.


modulation by virus of host translation

Any process in which a virus modulates the frequency, rate or extent of translation of host mRNA.


regulation of protein polyglycylation

Any process that modulates the frequency, rate or extent of protein polyglycylation.


positive regulation of tubulin deacetylase activity

Any process that activates or increases the frequency, rate or extent of tubulin deacetylase activity.


positive regulation of protein glutathionylation

Any process that increases the rate, frequency, or extent of protein glutathionylation. Protein glutathionylation is the protein modification process in which a glutathione molecule is added to a protein amino acid through a disulfide linkage.


positive regulation of mitochondrial translational initiation

Any process that activates or increases the frequency, rate or extent of the process preceding formation of the peptide bond between the first two amino acids of a protein in a mitochondrion.


regulation of plasma kallikrein-kinin cascade

Any process that modulates the frequency, rate, or extent of the plasma kallikrein-kinin cascade.


regulation of histone deacetylation

Any process that modulates the frequency, rate or extent of the removal of acetyl groups from histones.


negative regulation of histone ubiquitination

Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.


negative regulation of blood coagulation, extrinsic pathway

Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, extrinsic pathway.


negative regulation of mitochondrial translational elongation

Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial translational elongation.


negative regulation of lymphotoxin A production

Any process that stops, prevents, or reduces the frequency, rate, or extent of lymphotoxin A production.


regulation of CD86 production

Any process that modulates the frequency, rate or extent of CD86 biosynthetic process.


piRNA-mediated retrotransposon silencing by mRNA destabilization

A retrotransposon silencing mechanism in which mRNAs transcribed from transposons are targeted for degradation by a piRNA.


negative regulation of translation in response to osmotic stress

Any process that stops, prevents or reduces the rate of translation as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.


regulation of N-terminal peptidyl-serine acetylation

Any process that modulates the frequency, rate or extent of N-terminal peptidyl-serine acetylation.


regulation of translational frameshifting

Any process that modulates the frequency, rate or extent of translational frameshifting.


positive regulation of translation in response to osmotic stress

Any process that activates or increases the frequency, rate or extent of translation as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.


regulation of Toll receptor ligand protein activation cascade

Any process that modulates the frequency, rate or extent of the Toll receptor ligand protein activation cascade.


suppression by virus of host PKR signaling

Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of host PKR (Protein Kinase regulated by RNA) signaling. Host PKR signaling includes targets such as the translation initiation factor eIF2alpha, inhibiting protein synthesis as an antiviral response.


positive regulation of antimicrobial peptide biosynthetic process

Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide biosynthesis.


regulation of exonucleolytic catabolism of deadenylated mRNA

Any process that modulates the frequency, rate or extent of exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay.


regulation of blood coagulation, common pathway

Any process that modulates the frequency, rate or extent of blood coagulation, common pathway.


regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria

Any process that modulates the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.


regulation of protein O-linked glycosylation

Any process that modulates the frequency, rate or extent of protein O-linked glycosylation.


regulation of tubulin deacetylase activity

Any process that modulates the frequency, rate or extent of tubulin deacetylase activity.


siRNA-mediated long-distance post-transcriptional gene silencing

An siRNA-mediated posttranscriptional gene silencing pathway in which small interfering RNAs (siRNAs) direct the cleavage of target mRNAs, and in which the silencing signal originates in one tissue and occurs in a different tissue.


negative regulation of blood coagulation, intrinsic pathway

Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, intrinsic pathway.


regulation of peptidyl-serine phosphorylation of STAT protein

Any process that modulates the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein.


negative regulation of histone methylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of methyl groups to histones.


regulation of histone H3-K4 methylation

Any process that modulates the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.


regulation of translation at synapse, modulating synaptic transmission

Any process that modulates synaptic transmission by regulating translation occurring at the synapse.


negative regulation of protein monoubiquitination

Any process that stops, prevents or reduces the frequency, rate or extent of protein monoubiquitination.


regulation of translation in response to osmotic stress

Any process that modulates the frequency, rate or extent of the frequency, rate or extent of translation as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.


positive regulation of histone H3-K9 acetylation

Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.


negative regulation of N-terminal peptidyl-lysine acetylation

Any process that stops, prevents or reduces the frequency, rate or extent of N-terminal peptidyl-lysine acetylation.


regulation of peptidyl-lysine acetylation

Any process that modulates the frequency, rate or extent of peptidyl-lysine acetylation.


positive regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process

Any process that starts or increases the rate, frequency or extent of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by an SCF (Skp1/Cul1/F-box protein) complex, and mediated by the proteasome.


negative regulation of glycoprotein biosynthetic process

Any process that decreases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of a glycoprotein, a protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.


positive regulation of protein desumoylation

Any process that increases the frequency, rate or extent of protein desumoylation. Protein desumoylation is the process in which a SUMO protein (small ubiquitin-related modifier) is cleaved from its target protein.


regulation of lipoprotein oxidation

Any process that modulates the frequency, rate or extent of lipoprotein oxidation.


regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway

Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.


negative regulation of aspartic-type peptidase activity

Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type peptidase activity.


positive regulation of histone deacetylase activity

Any process that activates or increases the frequency, rate or extent of histone deacetylase activity.


regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis

Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.


negative regulation of amide metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving amides.


regulation of histone modification

Any process that modulates the frequency, rate or extent of the covalent alteration of a histone.


negative regulation of CD86 production

Any process that stops, prevents or reduces the frequency, rate or extent of CD86 biosynthetic process.


regulation of peptide hormone processing

Any process that modulates the rate, frequency or extent of peptide hormone processing. Peptide hormone processing is the generation of a mature peptide hormone by posttranslational processing of a prohormone.


suppression by virus of host translation initiation

Any process in which a virus prevents or reduces the frequency, rate or extent of host translation initiation, the host process preceding formation of the peptide bond between the first two amino acids of a protein.


negative regulation of urea catabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of urea catabolic process.


BCLAF1 and THRAP3 family member 3 isoform h2 (human)

A BCLAF1 and THRAP3 family member 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A2AJT9-2.


BCLAF1 and THRAP3 family member 3 isoform h1 (human)

A BCLAF1 and THRAP3 family member 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A2AJT9-1.


BCLAF1 and THRAP3 family member 3 isoform h3 (human)

A BCLAF1 and THRAP3 family member 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A2AJT9-3.


C-C motif chemokine 19, signal peptide removed form (human)

A C-C motif chemokine 19 (human) that has had the signal peptide removed. UniProtKB:Q99731, 22-98.


proinsulin (human)

A proinsulin in human. UniProtKB:P01308, 25-110.


insulin hormone (human)

An insulin hormone in human.


sodium ion uniporter activity

biolink:MolecularActivity biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

Catalysis of the active transport of a sodium ion across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.


membrane potential driven uniporter activity

Enables the active transport of a solute across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.


potassium ion uniporter activity

Catalysis of the active transport of a potassium ion across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.


envenomation resulting in myocyte killing in another organism

A process that begins with venom being forced into an organism by the bite or sting of another organism, killing heart myocytes and ultimately resulting in muscle damage in the bitten organism.


prospero homeobox protein 2 isoform h2 (human)

A prospero homeobox protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3B8N5-2.


T-cell surface glycoprotein CD4 N-glycosylated 4 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G17689DH. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G17689DH.


CD4 molecule

A protein that is a translation product of the human CD4 gene or a 1:1 ortholog thereof. CD4 is an accessory protein for MHC class-II antigen/T-cell receptor interaction. It is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence.


T-cell surface glycoprotein CD4 N-glycosylated 52 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G87633UQ. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G87633UQ.


T-cell surface glycoprotein CD4 N-glycosylated 51 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G78059CC.


T-cell surface glycoprotein CD4 N-glycosylated 41 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G45498YC. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G45498YC.


T-cell surface glycoprotein CD4 N-glycosylated 47 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G57413FT. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G57413FT.


T-cell surface glycoprotein CD4 N-glycosylated 39 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G38756OC. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G38756OC.


T-cell surface glycoprotein CD4 N-glycosylated 18 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G53450AF. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G53450AF.


T-cell surface glycoprotein CD4 N-glycosylated 16 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G45560HM. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G45560HM.


T-cell surface glycoprotein CD4 N-glycosylated 48 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G64132UH. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G64132UH.


T-cell surface glycoprotein CD4 N-glycosylated 31 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G18188WJ. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G18188WJ.


T-cell surface glycoprotein CD4 N-glycosylated 34 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G27561QX. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G27561QX.


T-cell surface glycoprotein CD4 N-glycosylated 5 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G18188WJ. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G18188WJ.


T-cell surface glycoprotein CD4 N-glycosylated 45 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G53752TA. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G53752TA.


T-cell surface glycoprotein CD4 N-glycosylated 19 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G53752TA. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G53752TA.


CD4 molecule isoform 1 phosphorylated 1 (human)

A CD4 molecule isoform 1 phosphorylated 1 in human.


T-cell surface glycoprotein CD4 N-glycosylated 38 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G37166HP. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G37166HP.


T-cell surface glycoprotein CD4 N-glycosylated 30 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G17689DH. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G17689DH.


T-cell surface glycoprotein CD4 N-glycosylated 17 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G52622SW. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G52622SW.


T-cell surface glycoprotein CD4 N-glycosylated 28 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G05950HG. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G05950HG.


T-cell surface glycoprotein CD4 N-glycosylated 36 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G35599NO. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G35599NO.


T-cell surface glycoprotein CD4 N-glycosylated 3 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G07995VK. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G07995VK.


T-cell surface glycoprotein CD4 N-glycosylated 37 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G36191CD.


T-cell surface glycoprotein CD4 N-glycosylated 21 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G57413FT. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G57413FT.


T-cell surface glycoprotein CD4 N-glycosylated 49 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G65890UA. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G65890UA.


T-cell surface glycoprotein CD4 N-glycosylated 10 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G35599NO. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G35599NO.


T-cell surface glycoprotein CD4 N-glycosylated 14 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G44276EF. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G44276EF.


T-cell surface glycoprotein CD4 N-glycosylated 29 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G07995VK. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G07995VK.


T-cell surface glycoprotein CD4 N-glycosylated 12 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G37166HP. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G37166HP.


T-cell surface glycoprotein CD4 N-glycosylated 2 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G05950HG. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G05950HG.


T-cell surface glycoprotein CD4 N-glycosylated 27 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G03860PZ. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G03860PZ.


T-cell surface glycoprotein CD4 N-glycosylated 22 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G64132UH. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G64132UH.


T-cell surface glycoprotein CD4 N-glycosylated 35 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G30460NZ. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G30460NZ.


T-cell surface glycoprotein CD4 N-glycosylated 26 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G87633UQ. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G87633UQ.


T-cell surface glycoprotein CD4 N-glycosylated 7 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G20966IA. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G20966IA.


T-cell surface glycoprotein CD4 N-glycosylated 15 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G45498YC. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G45498YC.


T-cell surface glycoprotein CD4 N-glycosylated 50 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G77252PU. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G77252PU.


T-cell surface glycoprotein CD4 N-glycosylated 20 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G53962WT. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G53962WT.


T-cell surface glycoprotein CD4 N-glycosylated 44 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G53450AF. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G53450AF.


T-cell surface glycoprotein CD4 N-glycosylated 6 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G20779SK. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G20779SK.


T-cell surface glycoprotein CD4 N-glycosylated 24 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G77252PU. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G77252PU.


T-cell surface glycoprotein CD4 N-glycosylated 1 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G03860PZ. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G03860PZ.


T-cell surface glycoprotein CD4 N-glycosylated 42 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G45560HM. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G45560HM.


T-cell surface glycoprotein CD4 N-glycosylated 13 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G38756OC. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G38756OC.


T-cell surface glycoprotein CD4 N-glycosylated 8 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G27561QX. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G27561QX.


T-cell surface glycoprotein CD4 N-glycosylated 40 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G44276EF. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G44276EF.


T-cell surface glycoprotein CD4 isoform 1 (human)

A CD4 molecule isoform 1 that is encoded in the genome of human.


T-cell surface glycoprotein CD4 N-glycosylated 46 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G53962WT. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G53962WT.


T-cell surface glycoprotein CD4 N-glycosylated 32 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G20779SK. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G20779SK.


T-cell surface glycoprotein CD4 N-glycosylated 33 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G20966IA. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G20966IA.


T-cell surface glycoprotein CD4 N-glycosylated 25 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G78059CC.


T-cell surface glycoprotein CD4 N-glycosylated 9 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G30460NZ. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G30460NZ.


CD4 molecule, signal peptide removed form (human)

A CD4 molecule, signal peptide removed form in human. UniProtKB:P01730, 26-458.


T-cell surface glycoprotein CD4 N-glycosylated 43 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-325 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G52622SW. Example: UniProtKB:P01730-1, Asn-325, MOD:00160~GNO:G52622SW.


T-cell surface glycoprotein CD4 N-glycosylated 11 (human)

A T-cell surface glycoprotein CD4 (human) that has been N-glycosylated at the residue equivalent to Asn-296 of the amino acid sequence represented by UniProtKB:P01730-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P01730-1, Asn-296, MOD:00160~GNO:G36191CD.


voltage-gated potassium channel KCNC1

A shaw-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNC1 gene or a 1:1 ortholog thereof. They contain an ATM motif at the C-terminus, following the S6 segment that allows interaction with axonal targeting machinery when exposed.


potassium voltage-gated channel subfamily C member 1 isoform h2 (human)

A potassium voltage-gated channel subfamily C member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48547-2.


potassium voltage-gated channel subfamily C member 1 isoform 1 (human)

A voltage-gated potassium channel KCNC1 isoform Short that is encoded in the genome of human.


acyl-coenzyme A synthetase ACSM1, mitochondrial isoform h2 (human)

An acyl-coenzyme A synthetase ACSM1, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q08AH1-2.


neuroplastin isoform h1 (human)

A neuroplastin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y639-1.


solute carrier family 2, facilitated glucose transporter member 4 isoform 1 (human)

A solute carrier family 2, facilitated glucose transporter member 4 isoform 1 that is encoded in the genome of human.


metanephric juxtaglomerulus cell development

The process whose specific outcome is the progression of a metanephric juxtaglomerulus cell over time, from its formation to the mature structure.


juxtaglomerulus cell development

The process whose specific outcome is the progression of a juxtaglomerulus cell over time, from its formation to the mature structure.


mesonephric juxtaglomerulus cell development

The process whose specific outcome is the progression of a mesonephric juxtaglomerulus cell over time, from its formation to the mature structure.


baculoviral IAP repeat-containing protein 2 isoform h2 (human)

A baculoviral IAP repeat-containing protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13490-2.


E3 ubiquitin ligase TRIM40

A tripartite motif-containing protein that is a translation product of the human TRIM40 gene or a 1:1 ortholog thereof.


E3 ubiquitin ligase TRIM40 isoform h1 (human)

An E3 ubiquitin ligase TRIM40 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6P9F5-1.


galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 isoform 1 (human)

A galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 isoform 1 that is encoded in the genome of human.


plasminogen activator inhibitor 1 RNA-binding protein isoform h1 (human)

A plasminogen activator inhibitor 1 RNA-binding protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NC51-1.


Catalysis of the reaction:peregrinol diphosphate = (13R)-9,13-epoxylabd-14-ene + diphosphate.


G protein-activated inward rectifier potassium channel

An inwardly rectifying potassium channel protein that has core architecture consisting of an Inward rectifier potassium channel domain (Pfam:PF01007), which may be preceeded by an Inward rectifier potassium channel N-terminal domain (Pfam:PF08466).


inward rectifier potassium channel 13 isoform 1 (human)

An inward rectifier potassium channel 13 isoform 1 that is encoded in the genome of human.


ATP-sensitive inward rectifier potassium channel 11

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ11 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 11 isoform h2 (human)

An ATP-sensitive inward rectifier potassium channel 11 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14654-2.


G protein-activated inward rectifier potassium channel 1 isoform 1 (human)

A G protein-activated inward rectifier potassium channel 1 isoform 1 that is encoded in the genome of human.


inward rectifier potassium channel 16

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ16 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 1

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ1 gene or a 1:1 ortholog thereof.


G protein-activated inward rectifier potassium channel 3 isoform 1 (human)

A G protein-activated inward rectifier potassium channel 3 isoform 1 that is encoded in the genome of human.


inward rectifier potassium channel 13

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ13 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 8

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ8 gene or a 1:1 ortholog thereof.


G protein-activated inward rectifier potassium channel 1

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ3 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 1 isoform h2 (human)

An ATP-sensitive inward rectifier potassium channel 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48048-2.


ATP-sensitive inward rectifier potassium channel 10 isoform 1 (human)

An ATP-sensitive inward rectifier potassium channel 10 isoform 1 that is encoded in the genome of human.


inward rectifier potassium channel 4

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ4 gene or a 1:1 ortholog thereof.


inward rectifier potassium channel 2

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ2 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 11 isoform 1 (human)

An ATP-sensitive inward rectifier potassium channel 11 isoform 1 that is encoded in the genome of human.


ATP-sensitive inward rectifier potassium channel 8 isoform 1 (human)

An ATP-sensitive inward rectifier potassium channel 8 isoform 1 that is encoded in the genome of human.


ATP-sensitive inward rectifier potassium channel 1 isoform 1 (human)

An ATP-sensitive inward rectifier potassium channel 1 isoform 1 that is encoded in the genome of human.


ATP-sensitive inward rectifier potassium channel 1 isoform h3 (human)

An ATP-sensitive inward rectifier potassium channel 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48048-3.


G protein-activated inward rectifier potassium channel 4

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ5 gene or a 1:1 ortholog thereof.


inward rectifier potassium channel 2 isoform 1 (human)

An inward rectifier potassium channel 2 isoform 1 that is encoded in the genome of human.


G protein-activated inward rectifier potassium channel 1 isoform h2 (human)

A G protein-activated inward rectifier potassium channel 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48549-2.


G protein-activated inward rectifier potassium channel 4 isoform 1 (human)

A G protein-activated inward rectifier potassium channel 4 isoform 1 that is encoded in the genome of human.


ATP-sensitive inward rectifier potassium channel 15

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ15 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 10

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ10 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 15 isoform 1 (human)

An ATP-sensitive inward rectifier potassium channel 15 isoform 1 that is encoded in the genome of human.


G protein-activated inward rectifier potassium channel 3

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ9 gene or a 1:1 ortholog thereof.


inward rectifier potassium channel 4 phosphorylated 1 (human)

An inward rectifier potassium channel 4 (human) that has been phosphorylated at Tyr-234. UniProtKB:P48050, Tyr-234, MOD:00048.


G protein-activated inward rectifier potassium channel 2

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ6 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 12

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ12 gene or a 1:1 ortholog thereof.


ATP-sensitive inward rectifier potassium channel 14

A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ14 gene or a 1:1 ortholog thereof.


inward rectifier potassium channel 13 isoform h2 (human)

An inward rectifier potassium channel 13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60928-2.


transcription elongation factor A protein-like 3

A protein that is a translation product of the human TCEAL3 gene or a 1:1 ortholog thereof.


SIGLEC family-like protein 1

A protein that is a translation product of the human SIGLECL1 gene or a 1:1 ortholog thereof.


protein-phytochromobilin linkage

The linkage of the chromophore phytochromobilin to phycocyanin or allophycocyanin.


protein-phytochromobilin linkage via S-phytochromobilin-L-cysteine

The linkage of the chromophore phytochromobilin to phycocyanin or allophycocyanin via S-phytochromobilin-L-cysteine.


neuropilin-1 N-glycosylated 1 (human)

A neuropilin-1 (human) that has been N-glycosylated at the residue equivalent to Asn-150 of the amino acid sequence represented by UniProtKB:O14786-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:O14786-1, Asn-150, MOD:00160~GNO:G59626AS.


beta-heterochromatin

biolink:CellularComponent biolink:AnatomicalEntity biolink:OrganismalEntity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssence biolink:SubjectOfInvestigation biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

A diffusely banded region of heterochromatin located between euchromatin and alpha-heterochromatin in the polytene chromosome chromocenter; normally replicated during polytenization.


spindle pole body-nuclear membrane anchor activity

The binding activity of a molecule that brings together a mitotic spindle pole body and the nuclear membrane, in order to maintain specific membrane location of the spindle pole body.


Ral guanine nucleotide dissociation stimulator isoform h2 (human)

A Ral guanine nucleotide dissociation stimulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q12967-2.


Ral guanine nucleotide dissociation stimulator

A protein that is a translation product of the human RALGDS gene or a 1:1 ortholog thereof.


Ral guanine nucleotide dissociation stimulator isoform h4 (human)

A Ral guanine nucleotide dissociation stimulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q12967-4.


Ral guanine nucleotide dissociation stimulator isoform h6 (human)

A Ral guanine nucleotide dissociation stimulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q12967-6.


Ral guanine nucleotide dissociation stimulator isoform h3 (human)

A Ral guanine nucleotide dissociation stimulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q12967-3.


Ral guanine nucleotide dissociation stimulator isoform h5 (human)

A Ral guanine nucleotide dissociation stimulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q12967-5.


Ral guanine nucleotide dissociation stimulator isoform h1 (human)

A Ral guanine nucleotide dissociation stimulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q12967-1.


cartilage oligomeric matrix protein N-glycosylated 2 (human)

A cartilage oligomeric matrix protein (human) that has been N-glycosylated at the residue equivalent to Asn-742 of the amino acid sequence represented by UniProtKB:P49747-1, in which the glycan composition is represented by GlyTouCan:G80920RR. Example: UniProtKB:P49747-1, Asn-742, MOD:00160~GNO:G80920RR.


Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: selenite(out) + H+(out) = selenite(in) + H+(in).


mimecan

A protein that is a translation product of the human OGN gene or a 1:1 ortholog thereof.


mimecan, signal peptide removed N-acetylaminoglucosyl-asparagine form (human)

A mimecan (human) that has had the signal peptide removed and that includes at least one N-acetylaminoglucosyl-asparagine. UniProtKB:P20774, 21-298, MOD:00831.


mimecan O-glycosylated 1 (human)

A mimecan (human) that has been O-glycosylated at the residue equivalent to Thr-80 of the amino acid sequence represented by UniProtKB:P20774-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P20774-1, Thr-80, MOD:00005~GNO:G43417UB.


mimecan isoform 1 (human)

A mimecan isoform 1 that is encoded in the genome of human.


solute carrier organic anion transporter family member 2A1

A solute carrier organic anion transporter family member that is a translation product of the human SLCO2A1 gene or a 1:1 ortholog thereof.


immunoglobulin heavy constant mu N-glycosylated 41 (human)

An immunoglobulin heavy constant mu (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:P01871-1, in which the glycan structure is represented by GlyTouCan:G65219TP. Example: UniProtKB:P01871-1, Asn-272, MOD:00160~GNO:G65219TP.


vacuolar ATPase assembly integral membrane protein VMA21 isoform h2 (human)

A vacuolar ATPase assembly integral membrane protein VMA21 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3ZAQ7-2.


28S ribosomal protein S28, mitochondrial, transit peptide removed form (human)

A 28S ribosomal protein S28, mitochondrial (human) that has had the transit peptide removed. UniProtKB:Q9Y2Q9, 72-187.


28S ribosomal protein S28, mitochondrial

A protein that is a translation product of the human MRPS28 gene or a 1:1 ortholog thereof.


cellular response to vitamin B6

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B6 stimulus. Vitamin B6 encompasses pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate.


UDP-galactose-UDP-N-acetylglucosamine galactose phosphotransferase activity

Catalysis of the reaction: UDP-N-acetyl-alpha-D-glucosamine + UDP-D-galactose = H+ + UDP-N-acetyl-6-(D-galactose-1-phospho)-D-glucosamine + UMP.


B-cell CLL/lymphoma 7 protein family member B isoform 1 (human)

A B-cell CLL/lymphoma 7 protein family member B isoform 1 that is encoded in the genome of human.


torsin-1B, signal peptide removed form (human)

A torsin-1B (human) that has had the signal peptide removed. UniProtKB:O14657, 25-336.


neuronal growth regulator 1 isoform h2 (human)

A neuronal growth regulator 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7Z3B1-2.


pancreatic alpha-amylase isoform h1 (human)

A pancreatic alpha-amylase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P04746-1.


protein SEC13 homolog isoform h4 (human)

A protein SEC13 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55735-4.


protein SEC13 homolog isoform h2 (human)

A protein SEC13 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55735-2.


protein SEC13 homolog, initiator methionine removed form (human)

A protein SEC13 homolog (human) that has had the initiator methionine removed. UniProtKB:P55735, 2-322.


protein SEC13 homolog isoform h1 (human)

A protein SEC13 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55735-1.


protein SEC13 homolog isoform h3 (human)

A protein SEC13 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55735-3.


stathmin-4 isoform 2 (human)

A stathmin-4 isoform 2 that is encoded in the genome of human.


stathmin-4 isoform h3 (human)

A stathmin-4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H169-3.


stathmin-4 isoform h4 (human)

A stathmin-4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H169-4.


stathmin-4 isoform 1 (human)

A stathmin-4 isoform 1 that is encoded in the genome of human.


DNA repair protein RAD51 homolog 1 isoform h3 (human)

A DNA repair protein RAD51 homolog 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q06609-3.


uromodulin N-glycosylated 126 (human)

A uromodulin (human) that has been N-glycosylated at the residue equivalent to Asn-275 of the amino acid sequence represented by UniProtKB:P07911-1, in which the glycan structure is represented by GlyTouCan:G99808VS. Example: UniProtKB:P07911-1, Asn-275, MOD:00160~GNO:G99808VS.


germ cell-specific gene 1-like protein isoform h1 (human)

A germ cell-specific gene 1-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UXU4-1.


germ cell-specific gene 1-like protein

A protein that is a translation product of the human GSG1L gene or a 1:1 ortholog thereof.


germ cell-specific gene 1-like protein isoform h3 (human)

A germ cell-specific gene 1-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UXU4-4.


germ cell-specific gene 1-like protein isoform h2 (human)

A germ cell-specific gene 1-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UXU4-3.


germ cell-specific gene 1-like protein isoform h4 (human)

A germ cell-specific gene 1-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UXU4-2.


oxysterol-binding protein-related protein 10 isoform h1 (human)

An oxysterol-binding protein-related protein 10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXB5-1.


phytanoyl-CoA dioxygenase domain-containing protein 1 isoform 1 (human)

A phytanoyl-CoA dioxygenase domain-containing protein 1 isoform 1 that is encoded in the genome of human.


reticulon-3, initiator methionine removed form (human)

A reticulon-3 (human) that has had the initiator methionine removed. UniProtKB:O95197, 2-1032.


MICOS complex subunit MIC60 isoform h1 (human)

A MICOS complex subunit MIC60 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q16891-1.


small nuclear ribonucleoprotein F isoform 1 (human)

A small nuclear ribonucleoprotein F isoform 1 that is encoded in the genome of human.


matrix-remodeling-associated protein 5 O-glycosylated 11 (human)

A matrix-remodeling-associated protein 5 (human) that has been O-glycosylated at the residue equivalent to Thr-1377 of the amino acid sequence represented by UniProtKB:Q9NR99-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9NR99-1, Thr-1377, MOD:00005~GNO:G43417UB.


cytohesin-interacting protein isoform h1 (human)

A cytohesin-interacting protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60759-1.


amyloid beta precursor like protein 2 O-glycosylated 3 (human)

An amyloid beta precursor like protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-43 of the amino acid sequence represented by UniProtKB:Q06481-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q06481-1, Thr-43, MOD:00005~GNO:G43417UB.


cell growth regulator with EF hand domain protein 1 isoform h2 (human)

A cell growth regulator with EF hand domain protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99674-2.


cell growth regulator with EF hand domain protein 1 isoform h4 (human)

A cell growth regulator with EF hand domain protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99674-4.


cell growth regulator with EF hand domain protein 1 O-glycosylated 1 (human)

A cell growth regulator with EF hand domain protein 1 (human) that has been O-glycosylated at the residue equivalent to Ser-159 of the amino acid sequence represented by UniProtKB:Q99674-4, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q99674-4, Ser-159, MOD:00002~GNO:G43417UB.


cell growth regulator with EF hand domain protein 1 O-glycosylated 2 (human)

A cell growth regulator with EF hand domain protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-111 of the amino acid sequence represented by UniProtKB:Q99674-4, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q99674-4, Thr-111, MOD:00005~GNO:G43417UB.


cell growth regulator with EF hand domain protein 1 isoform h3 (human)

A cell growth regulator with EF hand domain protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99674-3.


nephrin isoform h2 (human)

A nephrin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60500-2.


epididymal-specific lipocalin-12, signal peptide removed form (human)

An epididymal-specific lipocalin-12 (human) that has had the signal peptide removed. UniProtKB:Q6JVE5, 20-192.


mesonephric glomerular capillary formation

The process that gives rise to a mesonephric glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts.


protein-glutamine gamma-glutamyltransferase E isoform 1 (human)

A protein-glutamine gamma-glutamyltransferase E isoform 1 that is encoded in the genome of human.


actin-related protein 3C isoform h2 (human)

An actin-related protein 3C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9C0K3-2.


matrilin-2 isoform h4 (human)

A matrilin-2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O00339-4.


5'(3')-deoxyribonucleotidase, cytosolic type isoform h2 (human)

A 5'(3')-deoxyribonucleotidase, cytosolic type (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TCD5-2.


fermitin family homolog 2 isoform h2 (human)

A fermitin family homolog 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96AC1-2.


calpain-10 isoform F (human)

A calpain-10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9HC96-6.


IQCJ-SCHIP1 readthrough transcript protein isoform 1 (human)

An IQCJ-SCHIP1 readthrough transcript protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:B3KU38-1.


complexin-4 isoform 1 (human)

A complexin-4 isoform 1 that is encoded in the genome of human.


cilia- and flagella-associated protein 91 isoform h8 (human)

A cilia- and flagella-associated protein 91 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7Z4T9-8.


allergin-1 isoform h1 (human)

An allergin-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7Z6M3-1.


negative regulation of leucine-tRNA ligase activity

Any process that stops, prevents or reduces the frequency, rate or extent of leucine-tRNA ligase activity.


keratin-associated protein 4-7

A protein that is a translation product of the human KRTAP4-7 gene or a 1:1 ortholog thereof.


dysferlin

A protein that is a translation product of the human DYSF gene or a 1:1 ortholog thereof.


dysferlin isoform h8 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-8.


dysferlin isoform h2 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-2.


dysferlin isoform h12 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-12.


dysferlin isoform h15 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-15.


dysferlin isoform h6 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-6.


dysferlin isoform h14 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-14.


dysferlin isoform h1 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-1.


dysferlin isoform h11 (human)

A dysferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75923-11.